Yogologic ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  17.0% 15.6% 14.3% 14.8% 12.2%  
Credit score (0-100)  11 12 14 13 18  
Credit rating  BB BB BB BB BB  
Credit limit (kDKK)  0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  27.3 -18.2 -113 -60.6 -25.1  
EBITDA  27.3 -18.2 -113 -60.6 -25.1  
EBIT  27.3 -18.2 -113 -60.6 -25.1  
Pre-tax profit (PTP)  27.3 -19.1 -113.4 -61.3 -25.2  
Net earnings  24.9 -15.1 -88.5 -47.8 -19.8  
Pre-tax profit without non-rec. items  27.3 -19.1 -113 -61.3 -25.2  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  7.5 -7.7 -96.1 -144 -164  
Interest-bearing liabilities  0.0 199 234 128 143  
Balance sheet total (assets)  54.4 197 143 115 116  

Net Debt  -47.8 185 230 126 143  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  -100.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  27.3 -18.2 -113 -60.6 -25.1  
Gross profit growth  0.0% 0.0% -520.3% 46.2% 58.5%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  54 197 143 115 116  
Balance sheet change%  263.3% 261.2% -27.3% -19.7% 1.1%  
Added value  27.3 -18.2 -112.8 -60.6 -25.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  -1.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  63.0% -14.1% -50.9% -24.4% -9.3%  
ROI %  733.4% -17.6% -52.1% -33.4% -18.5%  
ROE %  221.7% -14.8% -52.1% -37.1% -17.1%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  13.7% -3.7% -40.2% -55.6% -58.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -174.8% -1,018.7% -203.8% -208.5% -568.9%  
Gearing %  0.0% -2,601.5% -243.8% -89.3% -87.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.9% 0.3% 0.3% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.2 0.3 0.4 0.4 0.3  
Current Ratio  1.2 2.6 1.3 0.8 0.7  
Cash and cash equivalent  47.8 13.9 4.4 2.0 0.2  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  7.5 122.3 33.9 -20.5 -40.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0